Mission Statement:

To improve the care and outcomes of kidney disease
patients worldwide through promoting coordination,
collaboration and integration of initiatives to develop
and implement clinical practice guidelines.

 

Work Group membership

WORK GROUP CO-CHAIRS
Michel Jadoul, MD, David Roth, MD,
Cliniques Universitaires Saint Luc, University of Miami,
Universite´ Catholique de Louvain, Miller School of Medicine,
Brussels, Belgium Miami, FL, USA

 

WORK GROUP
Charles Edward Alpers, MD, K Rajender Reddy, MD,
University of Washington Medical Center, University of Pennsylvania,
Seattle, WA, USA Philadelphia, PA, USA
Roy D Bloom, MD, Lionel Rostaing, MD, PhD,
University of Pennsylvania Medical Center, Centre Hospitalier Universitaire de Toulouse,
Philadelphia, PA, USA Toulouse, France
Fabrizio Fabrizi, MD, Lai Wei, MD, PhD,
Maggiore Policlinico Hospital, Peking University People’s Hospital,
Milan, Italy Beijing, China
Jacques Izopet, MD, Liaisons
Centre Hospitalier Universitaire de Toulouse, Miriam Alter, PhD,
Toulouse, France University of Texas Medical Branch,
Institute for Human Infections and Immunity,
Elizabeth Lindley, PhD, Galveston, TX, USA
Leeds Teaching Hospitals NHS Trust,
Leeds, UK Daniel Lavanchy, MD,
World Health Organization,
Paul Martin, MD, Geneva, Switzerland
Mount Sinai School of Medicine,
New York, NY, USA Catherine Meyers, MD,
National Institutes of Health,
José M Morales, MD, National Institute of Diabetes and Digestive and
Hospital Universitario 12 de Octubre, Kidney Diseases,
Madrid, Spain Bethesda, MD, USA
Svetlozar Natov, MD, Leonard B Seeff, MD,
Kindred Hospital Northeast, National Institutes of Health,
Braintree, MA National Institute of Diabetes and Digestive and
Kidney Diseases,
Stanislas Pol, MD, PhD, Bethesda, MD, USA
Hôpital Cochin,
Paris, France

EVIDENCE REVIEW TEAM

National Kidney Foundation Center for Guideline Development and Implementation
at Tufts-New England Medical Center, Boston, MA, USA:

Ethan Balk, MD, MPH, Project Director, Associate Program Director, Evidence-Based Medicine
Craig Gordon, MD, MS, Assistant Project Director
Amy Earley, BS, Research Assistant


INTERNATIONAL EVIDENCE REVIEW TEAM

Jonathan Craig, MBChB, FRACP, PhD, University of Sydney, Australia
John Ioannidis, MD, University of Ioannina, Greece

In addition, support and supervision were provided by
Katrin Uhlig, MD, MS, Program Director, Nephrology
Joseph Lau, MD, Program Director, Evidence-Based Medicine


KDIGO BOARD MEMBERS
Garabed Eknoyan, MD Norbert Lameire, MD
KDIGO Co-Chair KDIGO Co-Chair
Mona Al Rukhaimi, MD, FRCP Philip KT Li, MD, FRCP, FACP
Sharon P Andreoli, MD Francesco Locatelli, MD
Mustafa Arici, MD Alison MacLeod, MD
Kamal F Badr, MD Linda McCann, RD, LD, CSR
Rashad S Barsoum, MD Donna Mapes, DNSc, MS
Gavin J Becker, MD, FRACP Sergio A Mezzano, MD
Ezequiel Bellorin-Font, MD Sharon Moe, MD
Fred Brown, MBA, FACHE Saraladevi Naicker, MD
Emmanuel A Burdmann, MD Brian Pereira, MD, DM
Jorge Cannata-Andïa, MD Miguel C Riella, MD
Fernando Carrera, MD Jerome Rossert, MD, PhD
Jeremy R Chapman, MD Yusuke Tsukamoto, MD
Bruce Culleton, MD Raymond Vanholder, MD
Jean-Yves DeVos, RN Yves Vanrenterghem, MD
Kai-Uwe Eckardt, MD Rowan Walker, MBBS, FRACP, MD
Knud Erben Haiyan Wang, MD
Denis P Fouque, MD, PhD Christoph Wanner, MD
Vivekanand Jha, MD Jan Weening, MD
Michelle Josephson, MD David Wheeler, MD, FRCP
Bertram L Kasiske, MD Andrzej Wiecek, MD, PhD
Adeera Levin, MD, FRCPC Carmine Zoccali, MD
Nathan W Levin, MD, FACP

NKF-KDIGO GUIDELINE DEVELOPMENT STAFF
Kerry Willis, PhD, Senior Vice-President for Scientific Activities
Donna Fingerhut, Managing Director of Scientific Activities
Michael Cheung, Guideline Development Director
Dekeya Slaughter-Larkem, Guideline Development Project Manager
Sean Slifer, Scientific Activities Manager